Snowball logo
logo
NBIX_logo

Neurocrine Biosciences, Inc

NBIX NASDAQ
$129.78+$2.00  (1.57%)

Frequently asked questions

What sector does Neurocrine Biosciences, Inc (NBIX) operate in?

Neurocrine Biosciences, Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Neurocrine Biosciences, Inc (NBIX) current stock price?

As of the latest data, Neurocrine Biosciences, Inc stock price is $129.78, with a previous close of $127.78. Neurocrine Biosciences, Inc gained $2.00 in the last trading session, representing a 1.57% increase.

What is Neurocrine Biosciences, Inc (NBIX) current market capitalization?

Neurocrine Biosciences, Inc market cap is approximately 12.94 billion.

What is Neurocrine Biosciences, Inc (NBIX) Earnings Per Share (EPS)?

The trailing EPS is $4.13, and the forward EPS is $9.13.

What is Neurocrine Biosciences, Inc (NBIX) Price-to-Earnings (P/E) ratio?

Neurocrine Biosciences, Inc current P/E ratio is 31.42, with a forward P/E of 14.21.

What is Neurocrine Biosciences, Inc (NBIX) EBITDA?

Neurocrine Biosciences, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 299.50 million.

Does Neurocrine Biosciences, Inc (NBIX) pay dividends?

No. Neurocrine Biosciences, Inc does not pay a dividend.

How did Neurocrine Biosciences, Inc (NBIX) perform in its most recent earnings report?

In the last report (December 31, 2025), Neurocrine Biosciences, Inc posted an EPS surprise of 3.83% and a revenue surprise of 6.38%.

When is Neurocrine Biosciences, Inc (NBIX) next earnings report?

Neurocrine Biosciences, Inc is expected to release its next earnings report on March 31, 2026.

What is Neurocrine Biosciences, Inc (NBIX) beta (volatility) score?

Neurocrine Biosciences, Inc has a beta of 0.314, indicating lower volatility than the overall market.